Scientists hunt for biomarkers to predict immunotherapy success in head and neck cancer
NCT ID NCT07211139
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study is for people with advanced head and neck cancer who are receiving standard immunotherapy and chemotherapy. Researchers want to understand why only about 15% of patients respond well to these treatments. By analyzing tumor and blood samples before and after treatment, they hope to find biological markers that predict who will benefit most. The goal is to develop more personalized treatment strategies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung Medical Center
RECRUITINGSeoul, Seoul, 06351, South Korea
Conditions
Explore the condition pages connected to this study.